ArticleBreast cancer (Tokyo, Japan)2023

Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study.

Terufumi Kawamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.